Nov 03, 2023 / 03:30PM GMT
Operator
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin 9 Months 2023 Results Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Carlo Rosa - DiaSorin S.p.A. - CEO, GM & Executive Director
Thank you, operator, and good morning, good afternoon, and welcome to the Q3 conference call. As usual, I'm going to give some comments. At constant exchange rate, about the 3 legs of the business, the Immunodiagnostic, the Molecular Diagnostic and the Licensed Technology, and then I will let our CFO go through the numbers.
So if we start from the overall results, the quarter was in line with our expectation. Growth excluding COVID at constant exchange rate, it was 2% in the quarter, over 3% year-to-date. So it's in line with guidance and expectations, although if we look at the 3 legs of the business, we have different results.
So let's start from the Immunodiagnostics. Immunodiagnostics
Q3 2023 DiaSorin SpA Earnings Call Transcript
Nov 03, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers